Zaynich achieves over 97% efficacy in clinical study for meropenem-resistant gram-negative pathogens
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
Subscribe To Our Newsletter & Stay Updated